medigraphic.com
SPANISH

Revista Médica MD

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number 3

<< Back Next >>

Rev Med MD 2015; 6.7 (3)

Gorlin-Goltz syndrome: A clinical case presentation

Villegas-Pacheco J, Mojica-Padilla LA, López-Reyes SL, Arias-Patiño JJG
Full text How to cite this article

Language: Spanish
References: 10
Page: 227-230
PDF size: 846.81 Kb.


Key words:

Gorlin-Goltz syndrome, Basal Cell Nevus syndrome, keratocyst, pits.

ABSTRACT

The Gorlin-Goltz syndrome or Basal Cell Nevus is an ectodermic neoplasia, hereditary and autosomal dominantly by the mutation of PTCH1 genes in the 9q22 chromosome; PTCH2 gene 1p32 or the SUFU gene in 10q24-q25. It is a multi systemic rare disease with a prevalence of 1 in 57,000 to 150,000 people. It is characterized by the presence of multiple Basal Cell Nevus carcinomas, development of keratocystic odontogenic tumors, pits or palmoplantar dimples.


REFERENCES

  1. Safronova, M., Arantes M., Lima E., Domingos S., Almeida M., Moniz P. Síndrome de Gorlin Goltz Revisão das Características Neurorradiológicas e Maxilofaciais Ilustradas Com Dois Casos. Acta Med Port 2010; 23: 1119-1126.

  2. Méndez S., Torres S., Medina A., Alcalá D. Síndrome de Gorlin. Comunicación de un caso y revisión bibliográfica. Dermatología Rev Mex Volumen 53, Núm. 5, septiembre-octubre, 2009. 256-262

  3. Kis E., Balt E., Kinyo A., Varga E., Nagy N., Gyulai R., Kemény L., Oláh J. Successful Treatment of Multiple Basaliomas with Bleomycinbased Electrochemotherapy: A Case Series of Three Patients with Gorlin-Goltz Syndrome. University of Szeged, Szeged, Hungary. Acta Derm Venereol 2012; 92: 648–651

  4. Friedrich R. Diagnosis and Treatment of Patients with Nevoid Basal Cell Carcinoma Syndrome [Gorlin-Goltz Syndrome (GGS)]. Anticancer Research. University of Hamburg, Hamburg, Germany. 2007. 1783-1788

  5. Solari E., Zyromski C. Síndrome de Gorlin-Goltz, presentación de dos casos clínicos. Hospital San Martín, La Plata. RAOA VOL. 95 Nº 1. 2007. 21- 26

  6. Guminski A. New systemic treatment options for advanced basal cell carcinoma. Cancer Forum Volume 36 Number 3 November 2012

  7. Gutiérrez-Vargas R., Tellez-Rodriguez J., Teja- Angeles E., Duran-Gutiérrez A., Teliz-Meneses M. Síndrome de Gorlin-Goltz. Informe de un caso y revisión de la literatura. Acta Pediátrica de México Volumen 30, Núm. 1, enero-febrero, 2009.11-17

  8. Skvara H., Kalthoff F., Meingassner J., Wolff- Winiski B., Aschauer H. Topical Treatment of Basal Cell Carcinomas in Nevoid Basal Cell Carcinoma Syndrome with a Smoothened Inhibitor. Journal of Investigative Dermatology 131. 2011. 1735–1744

  9. Diaz-Fernandez J., Infante-Cossio P., Belmonte- Caro R., Ruiz-Laza L., García-Perla A., Gutiérrez-Pérez J. Síndrome névico baso-celular. Presentación de seis casos y revisión de la literatura. Med Oral Patol Oral Cir Bucal 2005;10: 57-66

  10. Howard Mora M. El síndrome del carcinoma nevoide de células basales (Síndrome de Gorlin- Goltz). Publicación Científica Facultad de Odontología, UCR, Nº11, 2009. 95-99




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med MD. 2015;6.7